Macrophages target tumor cells following monoclonal antibody therapy

Monoclonal antibodies directed against tumor antigens have proven effective for treating some forms of cancer. Despite the increasing use of monoclonal antibody therapy, it is not clear how these antibodies drive tumor removal.

In this issue of the Journal of Clinical Investigation, Marjolein van Egmond and colleagues at the VU University Medical Center found that macrophage populations mediate tumor cell removal following monoclonal antibody treatment by actively phagocytosing tumor cells. Macrophage-dependent tumor cell removal required both the high affinity and low affinity Fc receptors.

This study suggests that monoclonal antibody therapies that are optimized to enhance macrophage recruitment and activity may enhance removal of circulating in cancer patients.

More information: Macrophages eliminate circulating tumor cells after monoclonal antibody therapy, J Clin Invest. DOI: 10.1172/JCI66776

add to favorites email to friend print save as pdf

Related Stories

Monoclonal antibody targets, kills leukemia cells

Mar 25, 2013

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

Engineered anti-toxin antibodies improve efficacy

Jan 09, 2014

The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant region (Fc) of ...

Bright future ahead for antibody cancer therapy

Mar 15, 2012

Antibodies, once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center

Recommended for you

Computer model reveals cancer's energy source

1 hour ago

(Medical Xpress)—A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for ...

Britain to map 100,000 DNA code sequences

4 hours ago

British scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister said on Friday.

User comments